Remedium Capital Partners, LLC
Position in DMRA — Damora Therapeutics, Inc.
CIK 2104501
FORT LAUDERDALE, FL
Position in DMRA
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$52,977,750
+$50,205,667 QoQ
Shares Held
2,045,473
+1597.9% QoQ
Ownership
3.32%
of shares outstanding
% of Portfolio
19.30%
of 13F equity value
Holder Rank
#10
of 65 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DMRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Remedium Capital Partners, LLC holds $274,513,954 across 5 Biotechnology names. DMRA ranks #3 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
1,565,661 | $76,795,672 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
1,456,231 | $73,452,291 | |
| 3 | DMRA |
Damora Therapeutics, Inc.
This page
|
2,045,473 | $52,977,750 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
583,591 | $49,120,854 | |
| 5 | JBIO |
Jade Biosciences, Inc.
|
1,577,750 | $22,167,387 |
All Filings in DMRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,977,750 | 2,045,473 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $2,772,083 | 120,473 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||